🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a noninterventional, observational, long-term follow-up (LTFU) stud...
Status
Recruiting
Location
UC San Diego Moores Cancer Center
Start Date
2025-12-12
Trial ID
NCT06887348
Treatments Being Tested
Aim: The role of surgical castration and rosuvastatin treatment on lipid pr...
Status
Completed
Location
National Cancer Institute
Start Date
2019-01-15
Trial ID
NCT04776889
Treatments Being Tested
To estimate the clinical benefit of cemiplimab monotherapy versus cemiplima...
Status
Active Not Recruiting
Location
University of California San Diego
Start Date
2019-10-08
Trial ID
NCT04050436
Treatments Being Tested
Phase 1 study comprised of open-label, dose escalation, multiple cohorts of...
Status
Active Not Recruiting
Location
City of Hope
Start Date
2022-05-05
Trial ID
NCT04960579
Treatments Being Tested
Retinitis Pigmentosa (RP) is a devastating eye disease and at present there...
Status
Completed
Location
Wilmer Eye Institute, Johns Hopkins
Start Date
2017-02-15
Trial ID
NCT03063021
Treatments Being Tested
This is a Phase 1b, single-center, open-label study, evaluating efficacy an...
Status
Active Not Recruiting
Location
Rochester Dermatologic Surgery
Start Date
2023-06-16
Trial ID
NCT05858229
Treatments Being Tested
The purpose of this study is to assess the safety and efficacy of RP1 (admi...
Status
Active Not Recruiting
Location
Medical Dermatology Specialists
Start Date
2020-05-15
Trial ID
NCT04349436
Treatments Being Tested
This is a multicenter, open-label study of Intratumoral Vusolimogene Oderpa...
Status
Active Not Recruiting
Location
University of California, San Francisco
Start Date
2026-01-09
Trial ID
NCT06898970
Treatments Being Tested
The Phase 2 study is a multicenter, open-label study of RP1 to further inve...
Status
Active Not Recruiting
Location
University of Birmingham Alabama
Start Date
2017-09-20
Trial ID
NCT03767348
This early-phase study will examine Vusolimogene Oderparepvec, a geneticall...
Status
Recruiting
Location
UPMC Hillman Cancer Center
Start Date
2024-03-07
Trial ID
NCT06216938
Treatments Being Tested